Lionel Richie is reportedly recovering after undergoing an atrial fibrillation (Afib) ablation earlier this week.
The singer and “American Idol” judge, age 77, is said to have had a successful Afib ablation after complaining of feeling “dizzy” onstage in June and later undergoing tests for cardiac issues in August.
What is Atrial Fibrillation?
Afib is the most common arrhythmia and puts affected individuals at risk of blood clots, stroke, heart failure, and other heart-related complications. While Afib may be asymptomatic, common symptoms include palpitations, fatigue, and shortness of breath.
Treatment Options
Treatments can include heart rhythm- or rate-controlling medications, lifestyle management, cardioversion, and cardiac ablation. Afib ablation most commonly involves minimally invasive catheterization in an electrophysiology lab and focuses on pulmonary vein isolation (PVI) to prevent atrial arrhythmia recurrence.
It has not been disclosed what type of Afib Richie has or what modality of cardiac ablation he underwent.
Understanding Cardiac Ablation
Cardiac ablation is established as a first-line treatment for paroxysmal Afib (in which normal rhythm returns within 7 days); guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent Afib (when a single episode lasts more than 7 days), although the procedure is increasingly being used as first-line therapy in real-world settings.
In recent years, advances in ablation techniques have introduced new technologies for achieving durable PVI. The FDA approved the first system for pulsed field ablation (PFA) of paroxysmal and persistent Afib in 2023, marking a significant development beyond conventional radiofrequency and cryoablation techniques that rely on thermal damage to isolate abnormal electrical pathways and restore sinus rhythm.
PFA technology is believed to be safer, as its non-thermal mechanism reduces the risk of unintended damage to surrounding structures. PFA leverages high-voltage electrical fields to disrupt cell membranes, achieving PVI.
Recent Trials and Advancements
The technology was supported by this year’s randomized AVANT GUARD trial, which demonstrated that first-line treatment with PFA reduced the risk of recurrence of atrial arrhythmia among patients with persistent Afib—traditionally a group with poorer procedural outcomes when treated with thermal-based techniques compared to those with paroxysmal Afib.
However, new PFA systems have raised concerns about unique safety issues: real-world data indicated that early cases were linked with increased markers of non-target myocardial injury, hemolysis, acute kidney injury, and global cardiac dysfunction compared to conventional radiofrequency ablation.
Conclusion
Given Richie’s recovery time, three of his scheduled performances on the Sing a Song All Night Long Tour with Earth, Wind & Fire have been cancelled. However, he is still set to perform for a six-night concert series in Las Vegas in October and November.
Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult a healthcare professional for medical concerns or treatments.
Fuente: https://www.medpagetoday.com/popmedicine/popmedicine/123149
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
